A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the broader issue of how little is known about the…
Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse
